Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06729957 · ClinicalTrials.gov registry record · NA

Addressing Barriers to Care for Substance Use Disorder Trial

A NA study of Alcohol-Related Disorders and Substance Use Disorder (SUD), sponsored by Kaiser Permanente.

Active
Registry status
NA
Development phase
360
Enrollment target
1
Study location

NCT06729957: Active NA study of Alcohol-Related Disorders and Substance Use Disorder (SUD), sponsored by Kaiser Permanente.

NCT06729957 is a NA study of Alcohol-Related Disorders and Substance Use Disorder (SUD) that is active but no longer recruiting, run by Kaiser Permanente. The registered enrollment target is 360 participants, below the 1,749-participant average among 23 other Alcohol-Related Disorders trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06729957, a NA study of Alcohol-Related Disorders and Substance Use Disorder (SUD), is active but no longer recruiting, sponsored by Kaiser Permanente.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
360 participants
Enrollment target
1
Study location

Study Summary

The Addressing Barriers to Care for Substance Use Disorder Trial (ABC-SUD) is a cluster-randomized crossover trial, with clinicians (care coordinators) as the unit of randomization. This study will be conducted in a mental health access center within the Washington region of Kaiser Permanente. As part of usual care, patients contact the mental health access center and speak to a care coordinator to obtain an appointment with or contact information for potential venues to obtain treatment for substance use disorder. The experimental intervention, Care Navigation, will be evaluated for its potential to increase engagement in substance use disorder treatment among patients who contact the mental health access center. Care Navigation will be delivered by study care navigators, who are distinct from the health system's care coordinators.

Primary Outcome

Completion of ≥ 3 treatment visits for substance use disorder within 48 days of their assessment visit

Interventions

  • BEHAVIORAL Care Navigation

Study Locations (1)

Washington

  • Kaiser Permanente Washington - Seattle

Trial Details

FieldValue
Enrollment Target 360 participants
Start Date 2024-12-16
Est. Completion 2026-08-21
Phase NA
Kaiser Permanente

294 total trials

What the registry record for NCT06729957 still lists

NCT06729957 is an interventional study that assigns participants to a tested intervention. The registered 360 participants enrollment target is mid-sized for trials with a published cap, below the 1,749-participant average among 23 other Alcohol-Related Disorders trials with a reported enrollment target (79% lower).

The record links to 3 conditions, with Alcohol-Related Disorders appearing as the primary indexed condition, and to 1 intervention - of which Care Navigation is the first listed.

NCT06729957 reports a single indexed study location in Washington.

Frequently Asked Questions

What is clinical trial NCT06729957 about?

NCT06729957 is a clinical study titled "Addressing Barriers to Care for Substance Use Disorder Trial". The Addressing Barriers to Care for Substance Use Disorder Trial (ABC-SUD) is a cluster-randomized crossover trial, with clinicians (care coordinators) as the unit of randomization. This study will be conducted in a mental health access center within the Washington region of Kaiser Permanente. As p...

What is the current status of trial NCT06729957?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 360 participants. The study started on 2024-12-16. Estimated completion is 2026-08-21.

What conditions does trial NCT06729957 study?

This clinical trial studies the following conditions: Alcohol-Related Disorders, Substance Use Disorder (SUD), Drug Use Disorders.

What interventions are being tested in trial NCT06729957?

The interventions under investigation include: Care Navigation (BEHAVIORAL).

Who is sponsoring clinical trial NCT06729957?

This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06729957 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Alcohol-Related Disorders

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06729957's enrollment target sits among peer trials

360 7th of 23 higher than 17 of 23 other Alcohol-Related Disorders trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Alcohol-Related Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02747836 · 360 participants

    Ultrasound Analysis of Human Carpal Tunnel System

  • NCT04089046 · 360 participants · NA

    Telemedicine Enhanced Asthma Management - Uniting Providers for Teens (TEAM-UP for Teens)

  • NCT04130503 · 360 participants · NA

    The Recovery in Stroke Using PAP Study

  • NCT04160000 · 360 participants · Phase 4

    Treatment Of Atrial Fibrillation In Preserved Cardiac Function Heart Failure

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06729957, the US trial registry maintained by the National Library of Medicine. NCT06729957 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.